Target intelligence / Profile preview

CIBAR1 divergent transcript (CIBAR1-DT)

Target
CIBAR1-DT
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

CIBAR1 divergent transcript (CIBAR1-DT, LINC00535) is a long non-coding RNA located on chromosome 8 (chr8:93212888-93700512). It is classified as an lncRNA and does not encode a protein[1][3]. The primary molecular function noted is RNA binding, but no protein product or canonical drug target role has been established for this transcript[3]. There are no reported direct disease associations, biomarker roles, or interacting drugs as of the latest gene databases. CIBAR1 divergent transcript is distinct from the protein-coding gene CIBAR1 (CBY1-interacting BAR domain-containing protein 1), which is implicated in ciliogenesis and mitochondrial function, but the divergent transcript itself does not have a confirmed biological or therapeutic relevance in major disease indications[1][3]. In summary, CIBAR1 divergent transcript (LINC00535) is an annotated lncRNA gene with limited functional and clinical evidence, not considered a therapeutic target by standard criteria[1][3].

Other names
LINC00535long intergenic non-protein coding RNA 535CIBAR1-DT
02

Biological functions

Binding to RNA

Beyond the preview

Go deeper on CIBAR1 divergent transcript (CIBAR1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CIBAR1 divergent transcript (CIBAR1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call